Director Kim Buys 25,000 TRDA Shares

May 16, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The only insider buy on today’s list comes via a Form 4 filing by Entrada Therapeutics Inc $TRDA director Peter S. Kim.

Kim reported the acquisition of 25,000 shares, equivalent to $364,672, in the small-cap biotech company.

Here’s The Hot Corner, with data through May 16, 2024:

Have a great weekend. We’ll be back on Monday with more insider activity.

Filed Under: